Presence of Tissue Expanders Does Not Affect Radiotherapy Dose Distribution to Heart and Lungs.

IF 1.5 Q3 SURGERY
Plastic and Reconstructive Surgery Global Open Pub Date : 2025-05-28 eCollection Date: 2025-05-01 DOI:10.1097/GOX.0000000000006819
Jeewon Chon, Peter Laub, Mike Wesolowski, Safi Bajwa, Taylor Drew, Naomi Desai, Nazanin Azarvash, Jennifer S Wick, Timothy King
{"title":"Presence of Tissue Expanders Does Not Affect Radiotherapy Dose Distribution to Heart and Lungs.","authors":"Jeewon Chon, Peter Laub, Mike Wesolowski, Safi Bajwa, Taylor Drew, Naomi Desai, Nazanin Azarvash, Jennifer S Wick, Timothy King","doi":"10.1097/GOX.0000000000006819","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Breast cancer treatment often involves mastectomy and postmastectomy radiotherapy (PMRT). PMRT rates are increasing and can improve outcomes in node-positive cases. Although the risks of PMRT to reconstructed breasts are known, the influence of tissue expanders (TEs) on radiation to nearby organs such as the heart and lungs remains unclear.</p><p><strong>Methods: </strong>Patients who underwent total mastectomy and completed a full course of PMRT with 3-dimensional computer tomography planning between January 2014 and August 2022 at Loyola University Medical Center were included. Patient dose statistics for ipsilateral lung, heart, and clinical target volume, as well as demographics, clinical characteristics, PRMT boost, and bolus were collected. Dose statistics for ipsilateral lung and heart were compared between mastectomy versus mastectomy + TE, and dose statistics were compared between dichotomized TE intraoperative fill volumes. Correlations between dose statistics and BMI were analyzed.</p><p><strong>Results: </strong>A total of 124 patients were included in the study. There were no significant differences in lung or heart radiotherapy across all dose metrics between patients who underwent mastectomy versus mastectomy + TE, or between patients with TE fill volume 60 mL or less versus 60 mL or more. Correlations between BMI and heart maximum dose (<i>P</i> = 0.03) were significantly different and showed a positive, monoclonal correlation (correlation: 0.20, 95% confidence interval: 0.02-0.37).</p><p><strong>Conclusions: </strong>The presence of TE and intraoperative expander fill volume did not affect dose distribution or complications to the organs at risk. Increased BMI correlated with an increased maximum dose to the heart.</p>","PeriodicalId":20149,"journal":{"name":"Plastic and Reconstructive Surgery Global Open","volume":"13 5","pages":"e6819"},"PeriodicalIF":1.5000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12119047/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plastic and Reconstructive Surgery Global Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/GOX.0000000000006819","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Breast cancer treatment often involves mastectomy and postmastectomy radiotherapy (PMRT). PMRT rates are increasing and can improve outcomes in node-positive cases. Although the risks of PMRT to reconstructed breasts are known, the influence of tissue expanders (TEs) on radiation to nearby organs such as the heart and lungs remains unclear.

Methods: Patients who underwent total mastectomy and completed a full course of PMRT with 3-dimensional computer tomography planning between January 2014 and August 2022 at Loyola University Medical Center were included. Patient dose statistics for ipsilateral lung, heart, and clinical target volume, as well as demographics, clinical characteristics, PRMT boost, and bolus were collected. Dose statistics for ipsilateral lung and heart were compared between mastectomy versus mastectomy + TE, and dose statistics were compared between dichotomized TE intraoperative fill volumes. Correlations between dose statistics and BMI were analyzed.

Results: A total of 124 patients were included in the study. There were no significant differences in lung or heart radiotherapy across all dose metrics between patients who underwent mastectomy versus mastectomy + TE, or between patients with TE fill volume 60 mL or less versus 60 mL or more. Correlations between BMI and heart maximum dose (P = 0.03) were significantly different and showed a positive, monoclonal correlation (correlation: 0.20, 95% confidence interval: 0.02-0.37).

Conclusions: The presence of TE and intraoperative expander fill volume did not affect dose distribution or complications to the organs at risk. Increased BMI correlated with an increased maximum dose to the heart.

组织扩张器的存在不影响放疗剂量在心脏和肺部的分布。
背景:乳腺癌的治疗通常包括乳房切除术和乳房切除术后放疗(PMRT)。PMRT率正在增加,并可改善淋巴结阳性病例的预后。虽然PMRT对重建乳房的风险是已知的,但组织扩张器(TEs)对附近器官(如心脏和肺部)辐射的影响尚不清楚。方法:纳入2014年1月至2022年8月在洛约拉大学医学中心接受全乳切除术并完成全期PMRT和三维计算机断层扫描计划的患者。收集患者同侧肺、心脏和临床靶体积的剂量统计数据,以及人口统计学、临床特征、PRMT boost和bolus。比较乳房切除术与乳房切除术+ TE对同侧肺和心脏的剂量统计,比较TE二分法术中填充体积的剂量统计。分析剂量统计与BMI之间的相关性。结果:共纳入124例患者。在接受乳房切除术的患者与乳房切除术+ TE的患者之间,或TE填充量为60ml或更少的患者与60ml或更多的患者之间,肺或心脏放疗在所有剂量指标上没有显著差异。BMI与心脏最大剂量之间的相关性(P = 0.03)差异有统计学意义,呈单克隆正相关(相关性:0.20,95%可信区间:0.02 ~ 0.37)。结论:TE和术中扩张器填充量的存在不影响剂量分布或危及器官的并发症。体重指数的增加与心脏最大剂量的增加相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.20
自引率
13.30%
发文量
1584
审稿时长
10 weeks
期刊介绍: Plastic and Reconstructive Surgery—Global Open is an open access, peer reviewed, international journal focusing on global plastic and reconstructive surgery.Plastic and Reconstructive Surgery—Global Open publishes on all areas of plastic and reconstructive surgery, including basic science/experimental studies pertinent to the field and also clinical articles on such topics as: breast reconstruction, head and neck surgery, pediatric and craniofacial surgery, hand and microsurgery, wound healing, and cosmetic and aesthetic surgery. Clinical studies, experimental articles, ideas and innovations, and techniques and case reports are all welcome article types. Manuscript submission is open to all surgeons, researchers, and other health care providers world-wide who wish to communicate their research results on topics related to plastic and reconstructive surgery. Furthermore, Plastic and Reconstructive Surgery—Global Open, a complimentary journal to Plastic and Reconstructive Surgery, provides an open access venue for the publication of those research studies sponsored by private and public funding agencies that require open access publication of study results. Its mission is to disseminate high quality, peer reviewed research in plastic and reconstructive surgery to the widest possible global audience, through an open access platform. As an open access journal, Plastic and Reconstructive Surgery—Global Open offers its content for free to any viewer. Authors of articles retain their copyright to the materials published. Additionally, Plastic and Reconstructive Surgery—Global Open provides rapid review and publication of accepted papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信